Manganese‐enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: Dose‐dependent and temporal evolution of T1 contrast
Open Access
- 18 February 2005
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 53 (3), 640-648
- https://doi.org/10.1002/mrm.20368
Abstract
Manganese is a useful contrast agent for MRI of animals. Previously, it has been shown that systemic doses of MnCl2 provide unique contrast in the rodent brain, enabling visualization of neuroarchitecture. The present work investigates the dose and temporal dependence of brain enhancement after i.v. administration of MnCl2. Varying doses of MnCl2 (9–175 mg/kg) were administered to mice from 0 to 24 h prior to T1‐weighted manganese‐enhanced MRI (MEMRI) at 11.7 T. Pre‐MnCl2 T 1 values measured in different brain regions ranged from 1.17 ± 0.03 to 1.76 ± 0.01 s. Post‐MnCl2 T1 measured 24 hr after administration of MnCl2 were significantly decreased, even after the lowest dose of MnCl2. The largest decreases occurred in the pituitary gland, where post‐MnCl2 T 1 ranged from 231 ± 23 ms following the lowest dose to 143 ± 43 ms after the highest dose, while the smallest decreases were observed in cortex (post‐MnCl2 T 1 = 1060 ± 5 ms for low dose and 637 ± 5 ms for high dose). The contrast resulting after 14 hr did not change up to 24 hr. Enhancement first occurred in subarachnoid spaces, followed by ventricles and periventricular tissues, and finally reached the remainder of the brain. Cortical layers were detected at higher doses (>88 mg/kg) and olfactory bulb layers were detected with the lowest dose (9 mg/kg). Temporal evolution of the enhancement of the olfactory bulb layers was observed. In some regions of the brain, such as hippocampus and thalamus, the changes in contrast detected between 2 and 14 hr used very specific pathways. These results demonstrate that both the dose and the time after MnCl2 can be manipulated to optimize brain contrast in a region‐specific manner. Published 2005 Wiley‐Liss, Inc.Keywords
This publication has 36 references indexed in Scilit:
- Three‐dimensional MRI of cerebral projections in rat brain in vivo after intracortical injection of MnCl2NMR in Biomedicine, 2003
- Manganese ions as intracellular contrast agents: proton relaxation and calcium interactions in rat myocardiumNMR in Biomedicine, 2003
- Dynamic activity‐induced manganese‐dependent contrast magnetic resonance imaging (DAIM MRI)Magnetic Resonance in Medicine, 2002
- Validation of Diffusion Tensor Magnetic Resonance Axonal Fiber Imaging with Registered Manganese-Enhanced Optic TractsNeuroImage, 2001
- Manganese‐enhanced MRI of mouse heart during changes in inotropy†Magnetic Resonance in Medicine, 2001
- Manganese concentration in mouse brain after intravenous injectionJournal of Neuroscience Research, 2000
- Direct hepatic tumor injection in rats: Can it be used for analysis of MR imaging contrast agents?Journal of Magnetic Resonance Imaging, 1991
- Immunocytochemical localization of manganese superoxide dismutase (Mn-SOD) in the hippocampus of the ratNeuroscience Letters, 1990
- Species‐specific Mn2+/Mg2+ antiport from Mg2+‐loaded erythrocytesFEBS Letters, 1990
- Studies of factors affecting the design of NMR contrast agents: manganese in blood as a model systemMagnetic Resonance in Medicine, 1984